Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
The data is delayed by 15 minutes.
Description: Mallinckrodt public limited company develops, manufactures, markets, and distributes specialty pharmaceutical products and medical imaging agents worldwide. The company operates through two segments, Specialty Pharmaceuticals and Global Medical Imaging. The Specialty Pharmaceuticals segment provides Acthar, an injectable biopharmaceutical drug for use in various indications, including neurology, rheumatology, nephrology, and pulmonology; Ofirmev and Xartemis XR for pain indications; EXALGO extended-release tablets to treat chronic pain; and GABLOFEN injections for use in the management of spasticity of cerebral or spinal origin. It also offers generics and active pharmaceutical ingredients (API), such as hydrocodone and hydrocodone-containing tablets, oxycodone and oxycodone-containing tablets, and methylphenidate HCl extended-release tablets, as well as biologics, medicinal opioids, synthetic controlled substances, acetaminophen products, and other active ingredients. The Global Medical Imaging segment provi
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||39.32%||Sales Growth - Q/Q||5.03%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-1.44%||ROE||-3.57%||ROI||-1.9%|
|Current Ratio||2.86||Quick Ratio||2.41||Long Term Debt/Equity||2.75||Debt Ratio||0.15|
|Gross Margin||50.09%||Operating Margin||-4.3%||Net Profit Margin||-5.75%||Dividend Payout Ratio|
|Cash From Financing Activities||40.6 M||Cash From Investing Activities||-53 M||Cash From Operating Activities||365.5 M||Gross Profit||488.5 M|
|Net Profit||98.8 M||Operating Profit||95.2 M||Total Assets||12.81 B||Total Current Assets||2.22 B|
|Total Current Liabilities||775.7 M||Total Debt||3.99 B||Total Liabilities||7.63 B||Total Revenue||909.9 M|
|High 52 week||36.08||Low 52 week||11.99||Last close||17.73||Last change||-5.03%|
|RSI||10.84||Average true range||1.23||Beta||1.35||Volume||1.2 M|
|Simple moving average 20 days||-20.82%||Simple moving average 50 days||-31.17%||Simple moving average 200 days||-21.28%|
|Performance Week||-14.96%||Performance Month||-42.55%||Performance Quart||-40.26%||Performance Half||-12.18%|
|Performance Year||-25.19%||Performance Year-to-date||-21.41%||Volatility daily||3.48%||Volatility weekly||7.78%|
|Volatility monthly||15.95%||Volatility yearly||55.24%||Relative Volume||178.31%||Average Volume||2.26 M|
|New High||New Low|
2019-01-19 08:01:57 | See what the IHS Markit Score report has to say about Mallinckrodt Plc.
2019-01-16 17:06:39 | 5 Health Care Stocks in Gurus' Portfolios
2019-01-15 08:03:53 | See what the IHS Markit Score report has to say about Mallinckrodt Plc.
2019-01-14 12:09:00 | House Democrats launch drug-pricing probe into a dozen major health-care companies
2019-01-14 12:03:40 | The Mallinckrodt Spinoff Is a Short-Term Win
2019-01-14 06:45:00 | Mallinckrodt plc To Report Earnings Results For Fourth Quarter And Fiscal 2018
2019-01-11 09:30:02 | MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
2019-01-10 14:54:07 | Akorn AKRX Gets FDA Warning Letter for Illinois Facility
2019-01-03 17:43:10 | Cara CARA Up on IDMC's Recommendation to Continue Trial
2019-01-02 06:58:11 | Heron Gains on Priority Review Designation for Pain Drug
2018-12-26 08:02:06 | See what the IHS Markit Score report has to say about Mallinckrodt Plc.
2018-12-24 09:29:02 | Mallinckrodt's Inhaled Xenon Gas Therapy Enters Phase III
2018-12-24 08:01:51 | See what the IHS Markit Score report has to say about Mallinckrodt Plc.
2018-12-21 06:00:00 | Year in review: Hospital shakeups, urgent care invasion lead health care news cycle
2018-12-19 19:40:56 | [$$] Federal Judge Strikes Down New York Tax on Opioid Industry
2018-12-19 18:22:46 | See what the IHS Markit Score report has to say about Mallinckrodt Plc.
2018-12-19 16:30:40 | Judge blocks New York from enforcing opioid surcharge on companies
2018-12-18 08:01:58 | See what the IHS Markit Score report has to say about Mallinckrodt Plc.
2018-12-17 06:30:00 | Mallinckrodt To Present At 37th Annual J.P. Morgan Healthcare Conference
2018-12-15 22:56:24 | Is Mallinckrodt Public Limited Company MNK A Good Stock To Buy?
2018-12-13 09:26:02 | Mallinckrodt's Roxicodone Reformulation Gets CRL From FDA
2018-12-12 10:17:23 | FDA Snubs Mallinckrodt's Abuse-Deterrent Opioid Reformulation
2018-12-12 07:54:07 | FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller
2018-12-12 07:45:44 | [$$] FDA Doesn't Approve Mallinckrodt's Abuse-Deterrent Roxicodone
2018-12-12 06:58:00 | Mallinckrodt shares slide 4% premarket after pain treatment approval delayed
2018-12-12 06:54:30 | FDA declines to approve reformulated Mallinckrodt opioid
2018-12-07 15:14:08 | Mallinckrodt MNK to Separate Generics & Branded Businesses
2018-12-07 14:25:58 | Mallinckrodt company that remains in St. Louis faces big threats
2018-12-07 11:28:11 | Investors Hope Cleaving of Mallinckrodt Provides Meaty Returns
2018-12-06 11:37:14 | Mallinckrodt to spin off generics business, but to keep options open
2018-12-06 06:00:00 | Mallinckrodt Plans Spin-Off of Specialty Generics Business to Shareholders
2018-12-04 10:48:43 | Is Mallinckrodt Public Limited Company NYSE:MNK A Volatile Stock?
2018-11-26 16:08:00 | Why Mallinckrodt Stock Sank Today
2018-11-26 15:59:58 | 5 Top Stock Trades for Tuesday: GE, GM and Cyber Monday
2018-11-19 12:33:00 | Mallinckrodt Stock Can Rally Another 27%, Says Analyst
2018-11-19 11:15:18 | Canaccord Turns Bullish On Mallinckrodt: 4 Reasons Why
2018-11-19 07:32:28 | How Is Salix Pharmaceuticals Positioned in November?
2018-11-15 16:09:09 | Mallinckrodt Gets FDA Committee Vote for Abuse-Deterrent Drug
2018-11-15 08:45:00 | Consolidated Research: 2018 Summary Expectations for Tapestry, Mallinckrodt public limited company, Moxian, Applied Genetic Technologies, VistaGen Therapeutics, and Oasis Midstream Partners LP — Fundamental Analysis, Key Performance Indications